메뉴 건너뛰기




Volumn 12, Issue 12 II SUPPL., 1999, Pages 1175-1180

The Effect of Weight Loss Intervention on Antihypertensive Medication Requirements in the Hypertension Optimal Treatment (HOT) Study

Author keywords

Blood pressure; Drug treatment; Hypertension; Obesity; Weight loss

Indexed keywords

ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; ENALAPRIL; FELODIPINE; METOPROLOL;

EID: 0033396992     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(99)00123-5     Document Type: Article
Times cited : (75)

References (16)
  • 1
    • 0030713021 scopus 로고    scopus 로고
    • The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
    • Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch. Intern. Med 1997;157:2413-2446.
    • (1997) Arch. Intern. Med , vol.157 , pp. 2413-2446
  • 2
    • 0029760359 scopus 로고    scopus 로고
    • Body weight and blood pressure. Effects of weight reduction on hypertension
    • Jones DW: Body weight and blood pressure. Effects of weight reduction on hypertension. Am. J. Hypertens 1996;9:50s-54s.
    • (1996) Am. J. Hypertens , vol.9
    • Jones, D.W.1
  • 3
    • 0028559189 scopus 로고
    • Body mass index and blood pressure in Korean men and women: The Korean National Blood Pressure Survey
    • Jones DW, Kim JS, Andrew ME, Kim SJ, Hong YP: Body mass index and blood pressure in Korean men and women: the Korean National Blood Pressure Survey. J. Hypertens 1994;12:1433-7.
    • (1994) J. Hypertens , vol.12 , pp. 1433-1437
    • Jones, D.W.1    Kim, J.S.2    Andrew, M.E.3    Kim, S.J.4    Hong, Y.P.5
  • 4
    • 0026859812 scopus 로고
    • Cardiovascular consequences of obesity
    • Engl
    • Dustan HP: Cardiovascular consequences of obesity. Chin Med J (Engl) 1992;105:360-363.
    • (1992) Chin Med J , vol.105 , pp. 360-363
    • Dustan, H.P.1
  • 5
    • 0028006604 scopus 로고
    • The Hypertension Optimal Treatment (HOT) Study - Patient characteristics: Randomization, risk profiles, and early blood pressure results
    • Hansson L, Zanchetti A: The Hypertension Optimal Treatment (HOT) Study - patient characteristics: randomization, risk profiles, and early blood pressure results. Blood Press 1994;3:322-327.
    • (1994) Blood Press , vol.3 , pp. 322-327
    • Hansson, L.1    Zanchetti, A.2
  • 6
    • 0027359233 scopus 로고
    • Hypocaloric diet and antihypertensive drug treatment. A randomized controlled clinical trial
    • Darne B, Nivarong M, Tugaye A, et al: Hypocaloric diet and antihypertensive drug treatment. A randomized controlled clinical trial. Blood Press 1993;2:130-135.
    • (1993) Blood Press , vol.2 , pp. 130-135
    • Darne, B.1    Nivarong, M.2    Tugaye, A.3
  • 7
    • 0027185496 scopus 로고
    • Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension
    • Davis BR, Blaufox MD, Oberman A, et al: Reduction in long-term antihypertensive medication requirements. Effects of weight reduction by dietary intervention in overweight persons with mild hypertension. Arch Intern Med 1993;153:1773-1782.
    • (1993) Arch Intern Med , vol.153 , pp. 1773-1782
    • Davis, B.R.1    Blaufox, M.D.2    Oberman, A.3
  • 8
    • 0022606740 scopus 로고
    • Effects of weight loss on blood pressure and drug consumption in normal weight patients
    • Imai Y, Sato K, Abe K, Sasaki S, Nihei M, Youshinaga K, Sekino H: Effects of weight loss on blood pressure and drug consumption in normal weight patients. Hypertension 1986;8:223-228.
    • (1986) Hypertension , vol.8 , pp. 223-228
    • Imai, Y.1    Sato, K.2    Abe, K.3    Sasaki, S.4    Nihei, M.5    Youshinaga, K.6    Sekino, H.7
  • 9
    • 0026101821 scopus 로고
    • Weight reduction in obese hypertensive patients
    • Cohen MD, D'Amico FJ, Merenstein JH: Weight reduction in obese hypertensive patients. Fam Med 1991;23: 25-28.
    • (1991) Fam Med , vol.23 , pp. 25-28
    • Cohen, M.D.1    D'Amico, F.J.2    Merenstein, J.H.3
  • 10
    • 0028285128 scopus 로고
    • Role of insulin and norepinephrine in the hypertension of obesity
    • Maxwell MH, Heber D, Waks AU, Tuck ML: Role of insulin and norepinephrine in the hypertension of obesity. Am J Hypertens 1994;7:402-408.
    • (1994) Am J Hypertens , vol.7 , pp. 402-408
    • Maxwell, M.H.1    Heber, D.2    Waks, A.U.3    Tuck, M.L.4
  • 11
    • 0028822823 scopus 로고
    • Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals
    • Su HY, Sheu WH, Chin HM, Jeng CY, Chen YD, Reaven GM: Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals. Am J Hypertens 1995;8:1067-1071.
    • (1995) Am J Hypertens , vol.8 , pp. 1067-1071
    • Su, H.Y.1    Sheu, W.H.2    Chin, H.M.3    Jeng, C.Y.4    Chen, Y.D.5    Reaven, G.M.6
  • 12
    • 0024391834 scopus 로고
    • The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension
    • Kaplan NM: The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 1989;149:1514-1520.
    • (1989) Arch Intern Med , vol.149 , pp. 1514-1520
    • Kaplan, N.M.1
  • 13
    • 0027254745 scopus 로고
    • Erythrocyte Na(+)-H+ exchange activity in essential hypertensive and obese patients: Role of excess body weight
    • Delva P, Pastori C, Provoli E, Degan M, Arosio E, Mohtesi G, Steele A, Lechi A: Erythrocyte Na(+)-H+ exchange activity in essential hypertensive and obese patients: role of excess body weight. J Hypertens 1993; 11:823-830.
    • (1993) J Hypertens , vol.11 , pp. 823-830
    • Delva, P.1    Pastori, C.2    Provoli, E.3    Degan, M.4    Arosio, E.5    Mohtesi, G.6    Steele, A.7    Lechi, A.8
  • 14
    • 0027723336 scopus 로고
    • Is insulin-like growth factor 1 a determinant of renal haemodynamics in obesity hypertension?
    • Diez J, Ruilope LM, Rodicio JL: Is insulin-like growth factor 1 a determinant of renal haemodynamics in obesity hypertension? J Hypertens 1993;11(Suppl 5):S192-S193.
    • (1993) J Hypertens , vol.11 , Issue.5 SUPPL.
    • Diez, J.1    Ruilope, L.M.2    Rodicio, J.L.3
  • 15
    • 0029120410 scopus 로고
    • Combined renal effects of overweight and hypertension
    • Ribstein J, du Cailar G, Mimran A: Combined renal effects of overweight and hypertension. Hypertension 1995;26:610-615.
    • (1995) Hypertension , vol.26 , pp. 610-615
    • Ribstein, J.1    Du Cailar, G.2    Mimran, A.3
  • 16
    • 0027164570 scopus 로고
    • Obesity-induced hypertension: Renal function and systemic hemodynamics
    • Hall JE, Brands MW, Dixon WN, Smith MJ Jr: Obesity-induced hypertension: renal function and systemic hemodynamics. Hypertension 1993;22:292-299.
    • (1993) Hypertension , vol.22 , pp. 292-299
    • Hall, J.E.1    Brands, M.W.2    Dixon, W.N.3    Smith M.J., Jr.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.